Overview

The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study IS to - explore the underlying pathophysiology of chronic fatigue syndrome (CFS) in adolescents, particularly focusing on genetics, infections/immunology, endocrinology, autonomic control and cognitions - to assess the effect of clonidine (a drug that attenuates sympathetic nervous activity) in adolescent CFS.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Clonidine
Criteria
Inclusion Criteria:

- Persisting or constantly relapsing fatigue lasting 3 months or more.

- Functional disability resulting from fatigue to a degree that prevent normal school
attendance

Exclusion Criteria:

- Another disease process or current demanding life event that might explain the fatigue

- Another chronic disease (in particular pheochromocytoma, polyneuropathy, Renal
insufficiency)

- Permanent use of pharmaceuticals (including hormone drugs)

- Permanently bed-ridden

- Positive pregnancy test

- Evidence of reduced cerebral and/or peripheral circulation due to vessel disease

- Know hypersensitivity towards clonidine or inert substances (lactose, sakkarose) in
capsula

- Abnormal ECG (in particular bradyarrythmias due to sick sinus syndrome or AV-block.
Isolated ectopic beats do not lead to exclusion)

- Supine heart rate < 50 beats/min

- Supine systolic blood pressure < 85 mmHg

- Systolic blood pressure fall upon standing > 30 mmHg